+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Germany Respiratory Device Market 2019-2025

  • ID: 5013532
  • Report
  • February 2020
  • Region: Germany
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now


  • 3M Co.
  • Air Liquide S.A.
  • Bespak
  • Hamilton Medical AG
  • Novartis AG
  • Savara, Inc.
  • MORE
Germany Respiratory Device Market Size, Share & Trends Analysis Report by Product (Therapeutic Devices, Diagnostic and Monitoring Devices, and Consumables and Accessories), by End-User (Homecare and Hospitals and Clinics) and Forecast 2019-2025.

Germany respiratory device market was valued at around $1.1 billion in 2018 and is estimated to grow at a CAGR of around 6.5% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in the country. Further, well-developed healthcare infrastructure and the presence of key market players in the country are fueling the growth of the country’s market. Market players operating in the country are adopting various strategies which are providing the needful thrust to the market growth.

Germany respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.

Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include Bayer AG, ResMed Corp., Chiesi Farmaceutici S.P.A., GlaxoSmithKline PLC, Novartis AG, Boehringer Ingelheim International GmbH, and Drägerwerk AG., and others. Ingelheim-based Boehringer Ingelheim International GmbH collaborated with Weill Cornell Medicine in February 2017. The aim of the collaboration is to find new treatment approaches for chronic pulmonary diseases. The three-year collaboration aimed to develop novel treatments that could stop and decrease the progression of COPD. Additionally, in June 2017, the company announced a research collaboration with Harvard Stem Cell Institute, the alliance was formed to discover new treatment for idiopathic pulmonary fibrosis.

Research Methodology

The market study of the Germany respiratory device market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for respiratory device manufacturers, contract research organizations (CROs), the healthcare sector, market research firms, and government organizations, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Germany Respiratory Device Market Research and Analysis by Product
2. Germany Respiratory Device Market Research and Analysis by End-User

The Report Covers:
  • Comprehensive research methodology of the Germany respiratory device market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Germany respiratory device market.
  • Insights about market determinants which are stimulating the Germany respiratory device market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3


  • 3M Co.
  • Air Liquide S.A.
  • Bespak
  • Hamilton Medical AG
  • Novartis AG
  • Savara, Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Germany Respiratory Device Market by Product
5.1.1. Therapeutic Devices
5.1.2. Diagnostic and Monitoring Devices
5.1.3. Consumable and Accessories
5.2. Germany Respiratory Device Market by End-User
5.2.1. Homecare
5.2.2. Hospitals and Clinics

6. Company Profiles
6.1. 3M Co.
6.2. Acorda Therapeutics, Inc.
6.3. Adamis Pharmaceuticals Corp.
6.4. Adherium Ltd.
6.5. Air Liquide S.A.
6.6. AstraZeneca PLC
6.7. Bayer AG
6.8. Bespak
6.9. Boehringer Ingelheim International GmbH
6.10. Chiesi Farmaceutici S.P.A.
6.11. Gilbert Technologies B.V.
6.12. GlaxoSmithKline PLC
6.13. H&T Presspart Manufacturing Ltd.
6.14. Hamilton Medical AG
6.15. Koninklijke Philips N.V.
6.16. Medtronic PLC
6.17. Novartis AG
6.18. PMD Device Solutions Ltd.
6.19. ResMed Corp.
6.20. Savara, Inc.
6.21. Teicos Pharma Ltd.
6.22. Teva Pharmaceuticals Industries Ltd.
6.23. Vitalograph Ltd.
Note: Product cover images may vary from those shown
3 of 3
  • 3M Co.
  • Acorda Therapeutics, Inc.
  • Adamis Pharmaceuticals Corp.
  • Adherium Ltd.
  • Air Liquide S.A.
  • AstraZeneca PLC
  • Bayer AG
  • Bespak
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici S.P.A.
  • Gilbert Technologies B.V.
  • GlaxoSmithKline PLC
  • H&T Presspart Manufacturing Ltd.
  • Hamilton Medical AG
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Novartis AG
  • PMD Device Solutions Ltd.
  • ResMed Corp.
  • Savara, Inc.
  • Teicos Pharma Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Vitalograph Ltd.
Note: Product cover images may vary from those shown